Home › Pricey successor overtakes $1,000-per-pill hepatitis C drug
 

Keywords :   


Pricey successor overtakes $1,000-per-pill hepatitis C drug

2015-07-13 10:00:43| Biotech - Topix.net

Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions ... . This image provided by Gilead Sciences shows a bottle of the Hepititis drug Harvoni.

Tags: drug successor hepatitis pricey

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »